Insider trade

Amneal Pharmaceuticals (AMRX)Director sold ~$712K

Gautam Patel, Director at Amneal Pharmaceuticals, sold ~$712K of Amneal Pharmaceuticals shares.

~$712K
Approx. value · 80K sh @ $8.90: 1.81M
Holds after · shares reported

Traded: Mar 3, 2025
Filed: Mar 6, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Jan 2, 2025InsiderDirector sold ~$139K of AMRX shares in the open market
Jan 8, 2025InsiderDirector sold ~$501K of AMRX shares in the open market
Feb 3, 2025InsiderDirector sold ~$651K of AMRX shares in the open market
Mar 3, 2025 · this disclosureInsiderDirector sold ~$712K of AMRX shares in the open market

What came next

Mar 5, 2025Insider · 4 peopleInsiders: 4 sales (~$3.1M)
Mar 6, 2025InsiderOfficer sold ~$410K of AMRX shares in the open market
Mar 14, 2025Insider10% owner sold ~$41.8M of AMRX shares in the open market
Apr 1, 2025InsiderDirector sold ~$664K of AMRX shares in the open market
May 2, 2025InsiderDirector sold ~$30K of AMRX shares in the open market
May 5, 2025InsiderDirector sold ~$39K of AMRX shares in the open market
May 12, 2025InsiderDirector sold ~$380K of AMRX shares in the open market
May 16, 2025InsiderOfficer sold ~$372K of AMRX shares in the open market
Jun 10, 2025InsiderDirector sold ~$453K of AMRX shares in the open market
Jun 16, 2025InsiderDirector sold ~$761K of AMRX shares in the open market

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Amneal Pharmaceuticals

For Amneal Pharmaceuticals, OQRO holds 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AMRX page.

Other recent filings by Gautam Patel, Director

The full history of Gautam Patel, Director is on the profile page.

How this filing works

Other disclosures at Amneal Pharmaceuticals

Everything OQRO holds on this company is on its AMRX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data